185 related articles for article (PubMed ID: 37340431)
1. Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data.
Hoefsloot W; Dacheva E; van der Laan R; Krol M; van Ingen J; Obradovic M; Liu X
BMC Pulm Med; 2023 Jun; 23(1):218. PubMed ID: 37340431
[TBL] [Abstract][Full Text] [Related]
2. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
Kwon YS; Daley CL; Koh WJ
Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
[No Abstract] [Full Text] [Related]
3. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment for nontuberculous mycobacterial lung disease.
Kang YA; Koh WJ
Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
[TBL] [Abstract][Full Text] [Related]
5. Treatment of slowly growing mycobacteria.
Philley JV; Griffith DE
Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
8. Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.
Uno S; Asakura T; Morimoto K; Yoshimura K; Uwamino Y; Nishimura T; Hoshino Y; Hasegawa N;
BMC Pulm Med; 2020 Oct; 20(1):262. PubMed ID: 33036598
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines.
Ku JH; Henkle E; Aksamit TR; Barker A; Brunton AE; Winthrop KL;
Clin Infect Dis; 2023 Jan; 76(2):338-341. PubMed ID: 36134755
[TBL] [Abstract][Full Text] [Related]
10. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing nontuberculous mycobacterial lung disease and Mycobacterium tuberculosis lung disease on X-ray images using deep transfer learning.
Park M; Lee Y; Kim S; Kim YJ; Kim SY; Kim Y; Kim HM
BMC Infect Dis; 2023 Jan; 23(1):32. PubMed ID: 36658559
[TBL] [Abstract][Full Text] [Related]
12. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
Veziris N; Andréjak C; Bouée S; Emery C; Obradovic M; Chiron R
BMC Infect Dis; 2021 Nov; 21(1):1165. PubMed ID: 34789152
[TBL] [Abstract][Full Text] [Related]
13. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
Sawka A; Burke A
Clin Chest Med; 2023 Dec; 44(4):815-828. PubMed ID: 37890918
[TBL] [Abstract][Full Text] [Related]
14. Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Lung Disease in Patients With Mycobacterium avium Complex Lung Disease.
Furuuchi K; Fujiwara K; Uesgi F; Shimoda M; Seto S; Tanaka Y; Yoshiyama T; Yoshimori K; Kurashima A; Ohta K; Morimoto K
Clin Infect Dis; 2021 Jul; 73(1):e152-e157. PubMed ID: 32507892
[TBL] [Abstract][Full Text] [Related]
15. Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.
Henkle E; Hedberg K; Schafer S; Novosad S; Winthrop KL
Ann Am Thorac Soc; 2015 May; 12(5):642-7. PubMed ID: 25692495
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease.
Zo S; Kim H; Kwon OJ; Jhun BW
Microbiol Spectr; 2022 Aug; 10(4):e0108822. PubMed ID: 35950873
[TBL] [Abstract][Full Text] [Related]
17. Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review.
Anidi IU; Olivier KN
Clin Chest Med; 2023 Dec; 44(4):839-845. PubMed ID: 37890920
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination.
Lee MR; Yang CY; Shu CC; Lin CK; Wen YF; Lee SW; Ko JC; Wang JY; Lee LN; Yu CJ
Clin Microbiol Infect; 2015 Mar; 21(3):250.e1-7. PubMed ID: 25658545
[TBL] [Abstract][Full Text] [Related]
19. The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
Yan M; Brode SK; Marras TK
Chest; 2023 Feb; 163(2):281-291. PubMed ID: 36174743
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
Park S; Jo KW; Lee SD; Kim WS; Shim TS
Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
